Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticholinergic bronchodilators in combination.

R Pineda1, S I Rennard

  • 1University of Nebraska Medical Center, Omaha, Nebraska, USA.

Expert Opinion on Pharmacotherapy
|March 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Language and sound exposure across neonatal intensive care hospitalization and relationships with early outcome.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

Infant and Parent Outcomes Related to NICU-Based Co-occupational Engagement.

OTJR : occupation, participation and health·2023
Same author

Parent-infant interaction in the NICU: Challenges in measurement.

Early human development·2022
Same author

The effect of dry needling on gastrocnemius muscle stiffness and strength in participants with latent trigger points.

Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology·2020
Same author

Validation of the Spanish Version of the Food Allergy Quality of Life Questionnaire-Parent Form (S-FAQLQ-PF).

Journal of investigational allergology & clinical immunology·2017
Same author

Critical Roles of Kisspeptin in Female Puberty and Preovulatory Gonadotropin Surges as Revealed by a Novel Antagonist.

Endocrine reviews·2017

Chronic obstructive pulmonary disease (COPD) treatment involves bronchodilators to improve airflow and reduce breathlessness. This review focuses on using ipratropium bromide with other bronchodilators for COPD symptom management.

Area of Science:

  • Pulmonology
  • Pharmacology

Background:

  • Chronic obstructive pulmonary disease (COPD) is a leading cause of death and disability in the US, characterized by progressive lung function decline and dyspnea.
  • Bronchodilators are a cornerstone of COPD management, offering symptomatic relief and improving quality of life.
  • Several classes of bronchodilators exist, including anticholinergics, beta-agonists, and methylxanthines.

Purpose of the Study:

  • To review the use of ipratropium bromide, a key anticholinergic bronchodilator, in combination therapy for COPD patients.
  • To highlight the clinical benefits of combining ipratropium bromide with other bronchodilator classes.

Main Methods:

  • Literature review of studies investigating bronchodilator use in COPD.
  • Focus on combination therapy involving ipratropium bromide and other bronchodilators.

Related Experiment Videos

Main Results:

  • Anticholinergic bronchodilators like ipratropium bromide are effective in increasing airflow and reducing dyspnea in COPD.
  • Combination therapy with ipratropium bromide and other bronchodilators can enhance symptom control and patient outcomes.

Conclusions:

  • Ipratropium bromide, when used concomitantly with other bronchodilators, is a valuable therapeutic strategy for managing COPD.
  • Optimizing bronchodilator combinations can lead to significant improvements in quality of life for individuals with COPD.